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CLINICAL CASELife-Threatening Acute Pulmonary
Thromboembolism Following
Severe Carbon Monoxide Poisoning
A Plausible AssociationMaria Grazia De Gregorio, MD, Iacopo Olivotto, MD, PHD, Angela Migliorini, MD, Ruben Vergara, MD,
Piergiovanni Buonamici, MD, Niccolò Marchionni, MD, PHD, Renato Valenti, MDABSTRACTL
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MaA 57-year-old man admitted with severe carbon monoxide (CO) poisoning suffered life-threatening pulmonary
embolism (PE) after hyperbaric oxygen therapy, in the absence of other risk factors for thromboembolism, and was
successfully treated with thrombolysis. CO is a thrombophilic condition predisposing to PE and active surveillance
is advisable. (Level of Difficulty: Advanced.) (J Am Coll Cardiol Case Rep 2019;1:208–12) © 2019 The Authors.
Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).HISTORY OF PRESENTATION
A 57-year-old man was admitted to the emergency
department for carbon monoxide (CO) poisoning
suspicion, due to a malfunctioning heater at home.
He appeared awake but confused, with recent mem-
ory loss, nausea and vomiting, diffuse tremors, andEARNING OBJECTIVES
CO poisoning is associated with a complex
pathophysiology favoring thromboembolism.
Systematic studies focusing on relationship
between CO poisoning and risk of thrombo-
embolic complications are lacking.
The present observation supports the value
of surveillance DVT/PE and consideration
for routine prophylaxis in CO-poisoned
patients.
This issue may merit consideration in a future
expert consensus document.
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anisocoria and right-directed lateral nystagmus.
Arterial blood gas analysis (BGA) in oxygen showed
a lactic acidosis with high carboxyhemoglobin
(Figure 1). The electrocardiogram (ECG) revealed si-
nus tachycardia and diffuse repolarization abnor-
malities (Figure 1); the echocardiogram showed
diffuse left ventricular hypokinesia with ejection
fraction of 30% and normal right ventricular size and
function. A chest X-ray detected multiple lung con-
solidations with mild pleural effusion. Laboratory
tests revealed leukocytosis, increased serum creati-
nine and troponin I values (3.72 mg/l, normal range
0.00 to 0.09 mg/l).
PAST MEDICAL HISTORY
Past medical history was unremarkable; cardiovas-
cular risk factors included mild dyslipidemia and
well-controlled hypertension on pharmacological
therapy.https://doi.org/10.1016/j.jaccas.2019.05.024
y. Dr. Olivotto has received research grants from and
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AB BR E V I A T I O N S
AND ACRONYM S
BGA = blood gas analysis
CO = carbon monoxide
CT = computed tomography
DVT = deep venous thrombosis
ECG = electrocardiogram
HBOT = hyperbaric oxygen
therapy
pulmonary embolism
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209DIFFERENTIAL DIAGNOSIS
After hyperbaric oxygen therapy (HBOT), neurolog-
ical findings and BGA had improved, ECG and echo-
cardiogram were unchanged, and troponin I (3.89 mg/l)
and inflammatory markers (C-reactive protein
143 mg/l [normal range <9 mg/l]) were elevated. A
coronary angio–computed tomography (CT) scan was
negative, supporting the hypothesis of left ventric-
ular dysfunction induced by CO poisoning (1–3).
INVESTIGATIONS
By the next day, HBOT was repeated and the patient
improved steadily. Antibiotic therapy was adminis-
tered because of inflammatory markers and lung
consolidations. On the third day the echocardiogram
showed improved systolic function (LVEF 50%); a few
hours later, the patient suddenly complained of
worsening dyspnea followed by witnessed cardiac
arrest. He was promptly resuscitated with complete
recovery. The ECG showed sinus tachycardia with
new onset of incomplete right bundle block andFIGURE 1 Electrocardiographic, Echocardiographic, and Biochemical
Patient’s admission electrocardiogram with diffuse ST-T segment depress
and parasternal short axis views during pulmonary embolism are report
Arterial blood gas analyses and electrographic changes during admission
LA ¼ left atrium; LV ¼ left ventricle; MB ¼ moderator band; RA ¼ rightdiffuse ST-T abnormalities (Figure 1). The
echocardiogram revealed right ventricular
dilation and dysfunction with indirect evi-
dence of pulmonary hypertension, raising
clinical suspicion of pulmonary embolism
(PE). An angio-CT confirmed a massive bilat-
eral PE with large endoluminal defects of the
pulmonary arteries in their main, segmental,
and sub-segmental branches (Figure 2) and
multiple consolidations. An ultrasound ex-
amination failed to identify lower limbs deep
venous thrombosis (DVT).
MANAGEMENT
The patient was tachypneic and tachycardic and
N-terminal pro–B-type natriuretic peptide was
elevated (4.233 pg/ml, normal range <334 pg/ml).
Thrombolytic treatment was administered. About
30 min later, the right bundle block disappeared and
heart rate decreased. BGA demonstrated satisfactory
respiratory exchanges in Venturi mask with FiO2 50%;
there were no bleeding complications. In the following
PE =Findings
ion is shown (A). Echocardiographic biventricular telediastolic and telesystolic apical long axis
ed (B): red arrows show flattening of the interventricular septum, blue arrow indicates MB.
, after hyperbaric oxygen treatments, and after resuscitated cardiac arrest are shown (C).
atrium; RV ¼ right ventricle.
FIGURE 2 Thoracic Angio-CT Evolution
Thoracic angio-CT scans show a massive bilateral pulmonary thromboembolism and multiple parenchymal consolidations (circles) (A). The blue arrows indicate
endoluminal defects in the main and segmental branches of PA. Angio-CT scans performed after fibrinolysis show resolution of endoluminal defects of main and
segmental branches of PA (B); the red arrow indicates a triangular consolidation compatible with pulmonary infarction. Ao ¼ Aorta; CT ¼ computed tomography;
PA ¼ pulmonary artery; other abbreviations as in Figure 1.
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210days, he remained stable on unfractionated heparin,
and was later switched to rivaroxaban. Echocardio-
graphic monitoring showed progressive normalization
of biventricular function. Before discharge, a repeat
angio-CT showed resolution of bilateral defects,
except for sub-segmental branches and for a triangular
parenchymal consolidation compatible with pulmo-
nary infarction (Figure 2). Screening for thrombophilia
only showed slight increase of lipoprotein(a)
(392 mg/l [normal range <300 mg/l]) and factor VIII
(191% [normal range 60% to 150%]).
DISCUSSION
CO is a colorless, odorless, and tasteless gas that binds
with high affinity to many ferrous heme-containing
proteins involved in different cellular pathways (1–3),
especially to hemoglobin; thus, CO-bound hemoglobin
has reduced oxygen carrying and delivery capacity.
Furthermore, CO inhibits mitochondrial respiration
impairing adenosine triphosphate production in tis-
sues. Excessive CO concentration can activate platelets
by displacement of nitric oxide from platelet surfacehemoproteins; displaced free nitric oxide can react
with superoxide to produce peroxynitrite, further
inhibiting mitochondrial function and increasing
platelet and neutrophils activation. This process leads
to a vicious circle enhancing inflammation and oxida-
tive stress (3). CO cardiac toxicity is due to hypoxic
damage and adverse effects at the cellular and molec-
ular level. In particular, because CO binds the heme
group of myoglobin with greater affinity than oxygen,
its presence in the blood compromises oxygen supply
to the cardiomyocyte mitochondria, causing a switch
to anaerobic metabolism with consequent hypoxia,
lactic acidosis, and apoptosis. Moreover, CO triggers
endothelial dysfunction through enhanced trans-
capillary efflux, leukocyte sequestration within the
endothelial lining, and increased oxidation of plasma
lipoproteins (2). The clinical spectrum of cardiac
toxicity in CO poisoning includes angina, arrhythmias,
heart failure, myocardial stunning, myocardial infarc-
tion, cardiogenic shock, and sudden death.
By virtue of the complex pathophysiology outlined
above, there are several reasons why CO poisoning
may enhance risk of thrombosis (3,4) (Figure 3).
FIGURE 3 Possible Mechanisms Involved in Increased Prothrombotic Risk of CO Poisoning
Main possible biological mechanisms involved in increased prothrombotic risk in CO poisoning are related to the following: 1) biohumoral response by platelet and
leukocyte activation and increased release of acute-phase reaction proteins and coagulation factors; 2) endothelial cell injury, especially for unbalanced oxidative
stress; 3) myocardial injury (ranging from transitory ischemia to acute decompensation with peripheral circulatory failure); and 4) autonomic nervous system dereg-
ulation, characterized by hyperadrenergic state, responsible for an increased risk of arrhythmia, also enhanced by inhibition of oxidative phosphorylation and calcium
gradients alteration. CO ¼ carbon monoxide.
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211Epidemiological and environmental air studies have
demonstrated an increased risk of cardiovascular
events related to exposure to air pollutants and CO
(3–5). The occurrence of DVT/PE in CO poisoning has
been sporadically described (6,7) but systematic
evaluation of thrombophilic factors is lacking in this
setting. In the largest epidemiological study available
(5), CO poisoning was associated with a 3.85-fold
higher risk of DVT, although it was non-significantly
associated with PE. Conversely, no association be-
tween CO poisoning and bleeding risk has been re-
ported. Despite these data, neither PE nor CO
poisoning guidelines mention the potentially lethal
association of CO poisoning and DVT/PE (8,9).
Notably, our patient developed life-threatening PE
in the absence of other obvious risk factors such as
immobilization, trauma, or genetic evidence of
thrombophilia. Only a slight increase of lipoprotein(a)
and Factor VIII was identified; the latter was thought
to be secondary to inflammatory response to CO
poisoning (10).FOLLOW-UP
Two months later no neurological sequelae or cardi-
ological dysfunction were found. Oxygen saturation
was normal.
CONCLUSIONS
CO poisoning was the most likely trigger of life-
threatening PE, occurring in a normally mobilized
patient in the absence of other relevant risk factors
for PE/DVT. In agreement with pertinent literature,
our observation suggests that active surveillance
and prophylaxis for DVT/PE should be considered
in severe CO poisoning, including patients undergo-
ing HBOT, generally suffering from more severe
intoxication.
ADDRESS FOR CORRESPONDENCE: Dr. Renato Val-
enti, Cardiovascular Department, Careggi University
Hospital, Largo Brambilla 3, I-50134 Florence, Italy.
E-mail: renato.valenti2@tin.it.
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